Original Research
Published on 08 Apr 2025
Brosimine B and the biphasic dose-response: insights into hormesis and retinal neuroprotection
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558726
- 215 views
Type at least 3 characters
2,395 articles
Original Research
Published on 08 Apr 2025
Protective effects of 4-HBd on blood–brain barrier integrity in MCAO/R model rats based on brain pharmacokinetic characteristics
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1528839
- 229 views
Original Research
Published on 08 Apr 2025
Computational drug repurposing in Parkinson’s disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1539032
- 616 views
Editorial
Published on 08 Apr 2025
Editorial: Neuropharmacological intervention for severe mental illness and suicide prevention
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1599083
- 151 views
Original Research
Accepted on 07 Apr 2025
GluN2B influences the progression of status epilepticus by modulating calcium ion homeostasis through its interaction with CaMKIIα
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1550879
Original Research
Accepted on 07 Apr 2025
Lateral habenula astroglia modulate the potentiating antidepressant-like effects of bright light stimulation in intractable depression
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592909
- 109 views
Original Research
Accepted on 07 Apr 2025
Plasticity of ventral tegmental area disturbance during abstinence after repeated amphetamine exposure: restoration by selective activation of group II metabotropic glutamate receptors
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534101
Original Research
Published on 07 Apr 2025
Global research trends in biomarkers, therapeutic targets, and drugs for amyotrophic lateral sclerosis: a bibliometric and visualization analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588968
- 337 views
Systematic Review
Published on 07 Apr 2025
Neuroprotective effect and possible mechanism of edaravone in rat models of spinal cord injury: a systematic review and network meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1538879
- 214 views
Systematic Review
Accepted on 03 Apr 2025
Tailoring Dual Antiplatelet Therapy for Stroke Prevention: A Meta-Analysis of Timing, Duration, and Stroke Subtypes
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516402
Review
Published on 03 Apr 2025
Engineered nanoparticles for the treatment of Alzheimer’s disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1510798
- 371 views
Review
Published on 03 Apr 2025
Natural products protect against spinal cord injury by inhibiting ferroptosis: a literature review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1557133
- 370 views
Original Research
Accepted on 02 Apr 2025
Title Functional Ultrasound Imaging and Prewhitening Analysis Reveal MK-801-Induced Disruption of Brain Network Connectivity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1562102
Review
Published on 02 Apr 2025
Global research frontiers and thematic trends in opioid-free anesthesia over the past 20Â years: a bibliometric analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1562765
- 363 views
Original Research
Published on 02 Apr 2025
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559447
- 576 views
Original Research
Published on 01 Apr 2025
Increase of Brivaracetam serum concentration with introduction of Cenobamate
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571376
- 526 views